Bausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
| Revenue (TTM) | $5.10B |
| Gross Profit (TTM) | $3.05B |
| EBITDA | $609.00M |
| Operating Margin | 11.30% |
| Return on Equity | -5.39% |
| Return on Assets | 0.86% |
| Revenue/Share (TTM) | $14.42 |
| Book Value | $18.20 |
| Price-to-Book | 0.91 |
| Price-to-Sales (TTM) | 1.14 |
| EV/Revenue | 2.025 |
| EV/EBITDA | 16.50 |
| Quarterly Earnings Growth (YoY) | -88.60% |
| Quarterly Revenue Growth (YoY) | 9.80% |
| Shares Outstanding | $356.54M |
| Float | $44.54M |
| % Insiders | 87.57% |
| % Institutions | 11.53% |
Volatility is currently expanding